- GenoPalate, Inc., a Milwaukee-based early-stage nutritional genomics company, closed a $4m Series A financing round
- Backers included local investors
- The company also intends to use the funds to expand digital marketing and to continue the development of its research databases for addressing personalized nutrition
- GenoPalate provides nutrigenomics testing and analytical services for health-conscious consumers seeking to make healthy dietary choices
- The company interprets the customer’s DNA to help determine a personalized nutrition profile that shows them which foods are good and bad for their health
- Its home nutrition DNA test analyzes 100+ genetic markers that determine a person’s specific needs for vital nutrients such as carbohydrates, vitamin D, and sodium
